p53	O
hot	O
-	O
spot	O
mutants	O
increase	O
tumor	B-Cancer
vascularization	O
via	O
ROS	O
-	O
mediated	O
activation	O
of	O
the	O
HIF1	O
/	O
VEGF	O
-	O
A	O
pathway	O
.	O

The	O
function	O
of	O
p53	O
tumor	B-Cancer
suppressor	O
is	O
often	O
altered	O
in	O
various	O
human	O
tumors	B-Cancer
predominantly	O
through	O
missense	O
-	O
mutations	O
resulting	O
in	O
accumulation	O
of	O
mutant	O
proteins	O
.	O

We	O
revealed	O
that	O
expression	O
of	O
p53	O
proteins	O
with	O
amino	O
-	O
acid	O
substitutions	O
at	O
codons	O
175	O
(	O
R175H	O
)	O
,	O
248	O
(	O
R248W	O
)	O
,	O
and	O
273	O
(	O
R273H	O
)	O
,	O
representing	O
the	O
hot	O
-	O
spots	O
of	O
mutations	O
in	O
various	O
human	O
tumors	B-Cancer
,	O
increased	O
the	O
number	O
of	O
vessels	B-Multi-tissue_structure
in	O
HCT116	B-Cancer
human	I-Cancer
colon	I-Cancer
carcinoma	I-Cancer
xenografts	I-Cancer
and	O
,	O
as	O
a	O
result	O
,	O
accelerated	O
their	O
growth	O
.	O

Stimulation	O
of	O
tumor	B-Cancer
angiogenesis	O
was	O
connected	O
with	O
about	O
2	O
-	O
fold	O
increase	O
in	O
intracellular	B-Immaterial_anatomical_entity
level	O
of	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
.	O

Antioxidant	O
N	O
-	O
acetyl	O
-	O
l	O
-	O
aspartate	O
(	O
NAC	O
)	O
decreased	O
vessels	B-Multi-tissue_structure
number	O
in	O
tumors	B-Cancer
formed	O
by	O
cells	B-Cell
with	O
inactivated	O
p53	O
and	O
inhibited	O
their	O
growth	O
.	O

Effect	O
of	O
ROS	O
on	O
angiogenesis	O
in	O
tumors	B-Cancer
expressing	O
hot	O
-	O
spot	O
p53	O
mutants	O
was	O
correlated	O
with	O
their	O
ability	O
to	O
increase	O
a	O
content	O
of	O
HIF1	O
transcriptional	O
factor	O
responsible	O
for	O
up	O
-	O
regulation	O
of	O
VEGF	O
-	O
A	O
mRNAs	O
.	O

